FUROSTAT-500 TABLETS

Product Overview: Furostat-500 (Cefuroxime Axetil)

Furostat-500 Tablets, manufactured by Solvista Healthcare, is a high-potency antibiotic formulation containing Cefuroxime Axetil Tablets IP (500mg). Positioned as a “Powerful Protection against Bacterial Infections,” this medication belongs to the second-generation cephalosporin class of antibiotics, renowned for its balance of safety and broad-spectrum efficacy.

1. Composition and Pharmacological Class

The active pharmaceutical ingredient, Cefuroxime Axetil, is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime. Upon ingestion, it is rapidly absorbed from the gastrointestinal tract and hydrolyzed to release active cefuroxime into the circulation. It works by inhibiting bacterial cell wall synthesis, specifically targeting penicillin-binding proteins (PBPs), which leads to the eventual lysis and death of the bacterial cell.

2. Spectrum of Activity

As highlighted in the product documentation, Furostat-500 offers:

• Broad Spectrum Coverage: It is effective against a wide array of pathogens.
• Gram-Positive & Gram-Negative Efficacy: Unlike first-generation cephalosporins, Cefuroxime has enhanced stability against beta-lactamase enzymes produced by many Gram-negative bacteria, while maintaining strong activity against Gram-positive organisms like Streptococcus pneumoniae and Staphylococcus aureus.

3. Clinical Indications

Furostat-500 is indicated for a variety of susceptible bacterial infections, including but not limited to:

• Respiratory Tract Infections (RTIs): Highly effective for both upper and lower respiratory tract issues such as sinusitis, pharyngitis, tonsillitis, acute bronchitis, and community-acquired pneumonia.
• Urinary Tract Infections (UTIs): Used in the treatment of uncomplicated cystitis and pyelonephritis.
• Skin and Soft Tissue Infections: Treats localized bacterial skin infections, cellulitis, and wound infections.
• Other Susceptible Infections: Its broad reach makes it a versatile choice for various systemic bacterial threats.

4. Key Product Advantages

The promotional material for Furostat-500 emphasizes four critical clinical benefits:

• Effective Against Diverse Bacteria: Its ability to tackle both Gram-positive and Gram-negative strains makes it a reliable first-line or second-line choice for empirical therapy.
• Rapid Onset of Action: The pharmacokinetic profile ensures that therapeutic levels are reached quickly in the bloodstream and tissues, providing fast relief from symptoms.
• High Patient Compliance: The formulation is designed for ease of use, typically requiring fewer doses per day compared to older antibiotics, which ensures patients complete their full course of treatment.
• Quality Assurance: The product carries certifications from WHO-GMP, ISO, and is labeled as “Quality Assured,” indicating adherence to international manufacturing standards.

5. Presentation and Packaging

Furostat-500 is presented in a professional 10 x 10 tablet blister pack (100 tablets total per box). The branding utilizes a “Shield” motif to symbolize the protection it offers the human immune system against invading microbes.